Speaker illustration

Doctor Laura Obici

I.R.C.C.S. San Matteo Polyclinic, Pavia (Italy)

Member of:

Panel discussion and Q&A

Event: Heart Failure 2024

Topic: Cardiac Amyloidosis

Session: More than cardiomyopathy: a multidisciplinary approach to transthyretin amyloidosis (ATTR)

Thumbnail

Unfolding the ATTR patient journey

Event: Heart Failure 2024

Topic: Cardiac Amyloidosis

Session: More than cardiomyopathy: a multidisciplinary approach to transthyretin amyloidosis (ATTR)

Thumbnail

Meeting summary and conclusions

Event: ESC Congress 2023

Topic: Cardiac Amyloidosis

Session: The advancing management of transthyretin amyloidosis: a practical guide

Thumbnail

Long-term management of transthyretin amyloidosis

Event: ESC Congress 2023

Topic: Cardiac Amyloidosis

Session: The advancing management of transthyretin amyloidosis: a practical guide

Thumbnail

Discussion and closing remarks

Event: EACVI 2023

Topic: Cross-Modality and Multi-Modality Imaging Topics

Session: Hereditary transthyretin (ATTRv) amyloidosis: multi-modality imaging for a multisystem disease

Thumbnail

Improving outcomes in ATTRv amyloidosis through timely cardiac imaging

Event: EACVI 2023

Topic: Cross-Modality and Multi-Modality Imaging Topics

Session: Hereditary transthyretin (ATTRv) amyloidosis: multi-modality imaging for a multisystem disease

Thumbnail

Questions & answers - An un-nerve-ing disease: diagnosing hATTR amyloidosis beyond the heart.

Event: Heart Failure 2019

Topic: Cardiovascular Disease in Special Populations

Session: An un-nerve-ing disease: diagnosing hATTR amyloidosis beyond the heart

Thumbnail

Everything you were too nerve-ous to ask (your neurologist) about hATTR amyloidosis.

Event: Heart Failure 2019

Topic: Cardiovascular Disease in Special Populations

Session: An un-nerve-ing disease: diagnosing hATTR amyloidosis beyond the heart

Thumbnail

Chair welcome - An un-nerve-ing disease: diagnosing hATTR amyloidosis beyond the heart.

Event: Heart Failure 2019

Topic: Cardiovascular Disease in Special Populations

Session: An un-nerve-ing disease: diagnosing hATTR amyloidosis beyond the heart

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb